Used as a carbonic anhydrase inhibitor, this compound has applications in the treatment of glaucoma by reducing intraocular pressure. It helps decrease the production of aqueous humor in the eye through inhibition of enzyme activity. Also investigated for its potential diuretic properties, supporting use in managing fluid retention conditions. Its sulfonamide groups are critical for binding to the active site of carbonic anhydrase enzymes, making it effective in low concentrations. Additionally, it serves as an intermediate in the synthesis of other biologically active sulfonamide derivatives.